| 000 | 01766 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517173153.0 | ||
| 264 | 0 | _c20180508 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2314-7156 | ||
| 024 | 7 |
_a10.1155/2017/7807313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLai, Chao-Yang | |
| 245 | 0 | 0 |
_aNatural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation. _h[electronic resource] |
| 260 |
_bJournal of immunology research _c2017 |
||
| 300 |
_a7807313 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAminoquinolines _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aCurcumin _xtherapeutic use |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 |
_aDermatitis _xdrug therapy |
| 650 | 0 | 4 |
_aEndosomes _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImiquimod |
| 650 | 0 | 4 |
_aIndazoles _xadverse effects |
| 650 | 0 | 4 |
_aIsonicotinic Acids _xadverse effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSkin _ximmunology |
| 650 | 0 | 4 |
_aStilbenes _xtherapeutic use |
| 650 | 0 | 4 |
_aToll-Like Receptor 7 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aToll-Like Receptor 8 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aToll-Like Receptor 9 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aToll-Like Receptors _xantagonists & inhibitors |
| 700 | 1 | _aSu, Yu-Wen | |
| 700 | 1 | _aLin, Kuo-I | |
| 700 | 1 | _aHsu, Li-Chung | |
| 700 | 1 | _aChuang, Tsung-Hsien | |
| 773 | 0 |
_tJournal of immunology research _gvol. 2017 _gp. 7807313 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2017/7807313 _zAvailable from publisher's website |
| 999 |
_c27549809 _d27549809 |
||